Telescope Biotech Fund was created through a partnership between Andbank, a group specialized in private banking and wealth management, and Ysios Capital, Spain’s leading biotechnology investor, wit...
In the Iberian market, growth has been driven mainly by increased foreign investment inflows. Over the past year, international groups have entered various segments of the value chain, ranging from cl...
Syngoi is a Contract Development and Manufacturing Organisation (CDMO) specialising in synthetic DNA for advanced therapies, a critical component for therapeutic applications such as mRNA vaccines, ge...
Oriva Therapeutics, a women’s health company developing first-in-class and best-in-class approaches to treat chronic, prevalent conditions affecting women, announced today its incorporation, as well...
The acquisition of Ceres Biotics marks another significant milestone in SAS Group’s strategy to build a global leader in agricultural biosolutions. Ceres Biotics brings a highly complementary produc...
This transaction allows SAS Group to strengthen its global leadership in biosolutions by incorporating microorganism-based technology and a highly complementary product portfolio. For Ceres Biotics, t...
The company is developing an artificial intelligence platform that simplifies the design and execution of clinical trials, from patient selection to the choice of hospitals, with the aim of reducing i...
Orikine Bio develops therapies capable of 'reprogramming' the immune system, similar to how software engineers rewrite faulty code to repair computer systems.
The Healthcare sector remains one of the most resilient engines of the European M&A market, despite a 2025 marked by increased macroeconomic uncertainty. According to the Healthcare Update Q4 2025, Sp...
The relationship with the company began in 2021, when Agomab acquired Origo Biopharma, one of their portfolio companies, marking Asabys’s first exit. Since then, they have continued to support Agom...
For years, oncology drug launches relied on standardized approaches. But tightening price controls, fiercer competition, and fast-evolving markets are challenging this model. Creating sustainable valu...
The forum Invertir en Ciencia Sí es Rentable has recognized the Galician company Centum and the Catalan biotech ecosystem Biocat for their contribution to the development of innovation in health and ...
